|
Quality of life assessment in patients with advanced renal cancer: CAVIREN study. |
|
|
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Janssen; Pfizer; Sanofi |
|
|
Consulting or Advisory Role - GlaxoSmithKline |
Research Funding - GlaxoSmithKline (Inst) |
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen-Cilag |
|
|
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer |
Speakers' Bureau - GlaxoSmithKline; Novartis |
Travel, Accommodations, Expenses - Pfizer |
|
|
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Novartis; Pfizer |
Speakers' Bureau - Bayer; GlaxoSmithKline; Novartis; Novartis; Pfizer |
Travel, Accommodations, Expenses - GlaxoSmithKline; Pfizer |
|
|
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; Pfizer |
Speakers' Bureau - Astellas Pharma; Pfizer |
|
Enrique González-Billalabeitia |
No Relationships to Disclose |
|
Aranzazu Gonzalez del Alba |
Consulting or Advisory Role - Astellas Pharma; Bayer; Sanofi |
Speakers' Bureau - Astellas Pharma; Bayer; GlaxoSmithKline; Janssen-Cilag |
|
|
Speakers' Bureau - Astellas Pharma; Bayer; GlaxoSmithKline; Janssen-Ortho; Pfizer |
Expert Testimony - Pfizer |
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer |